Delivery Order SPE2DR25D2104-SPE2DR26F3QLF
- Not listed
- The Defense Logistics Agency awarded a $14,720.65 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of five (5s). This is a firm fixed price delivery order with a completion date of December 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsules with a ceiling value of $1,842.89. This competitively awarded, firm fixed-price delivery order was issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The pharmaceutical product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a $1,792.44 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules (6-count units) under a firm fixed price contract. This non-set-aside award was issued on December 12, 2025, with an ultimate completion date of December 15, 2025. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,623.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for Aprepitant 80 mg capsules (6-count units) on December 12, 2025, with completion scheduled for December 15, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of 5s, with a ceiling value of $3,674.66 and an ultimate completion date of October 21, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging (5s) with a ceiling value of $30,197.23. This firm fixed price delivery order, awarded on November 26, 2025, with an ultimate completion date of November 28, 2025, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Aprepitant 80 mg capsule unit dose packages in quantities of six, with a contract ceiling value of $10,700.65. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the order is scheduled for completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of five, with a ceiling value of $2,107.60 and a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by June 12, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea and vomiting (CINV)...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.19 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging of 5s. This competitive award, executed on April 23, 2025, with an ultimate completion date of April 24, 2025, reflects a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QLFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,024.13 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging. This firm fixed price, non-set-aside contract was executed on December 3, 2025, with an ultimate completion date of December 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Aprepitant is a chemotherapy-induced nausea and vomiting (CINV) prevention medication commonly utilized in military and federal healthcare settings. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle that extends through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen serves the Defense Health Agency, military health systems, and other government healthcare entities through this prime contract vehicle. The company's extensive portfolio with DLA encompasses a wide range of medications and medical supplies across multiple therapeutic domains, positioning it as a key supplier supporting military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/2/25 |